Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia
- 1 September 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 336 (8716) , 670-673
- https://doi.org/10.1016/0140-6736(90)92158-e
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Termination of refractory ventricular tachycardia by a combination of intravenous sotalol and overdrive ventricular pacingClinical Cardiology, 1987
- Successful termination of combined rapid atrial flutter/fibrillation and ventricular tachycardia by intravenous sotalolPostgraduate Medical Journal, 1987
- Intravenous flecainide acetate for the clinical management of paroxysmal tachycardiasClinical Cardiology, 1987
- Effect of intravenous and oral flecainide on ventricular tachycardiaInternational Journal of Cardiology, 1986
- Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardiaEuropean Heart Journal, 1984
- Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.Circulation, 1984
- Intravenous mexiletine in management of lidocaine-resistant ventricular tachycardiaAmerican Heart Journal, 1983
- Disopyramide—An Effective Treatment for Lignocaine Resistant Ventricular DysrhythmiasScottish Medical Journal, 1979
- Electrical Stimulation of the Heart in Patients with Ventricular TachycardiaCirculation, 1972
- The Antiarrhythmic Properties of Lidocaine and Procaine AmideCirculation, 1963